Sarcopenia in Asia

Sarcopenia is a progressive and generalized loss of muscle mass and either a loss of muscle strength or physical performance. Its prevalence increases with age and is associated with multiple unfavorable clinical outcomes. The operational definitions and diagnostic strategy of sarcopenia in Asia is currently based on the consensus of the Asian Working Group of Sarcopenia (AWGS) which requires measurements of muscle mass, muscle strength, and physical performance. This article reviewed the epidemiology, impact, pathophysiology, recommended tools and their cut-offs for diagnosis of sarcopenia in Asia according to the consensus of the AWGS and existing evidence in Asia. It is clear that exercise, diet and nutrition are beneficial for sarcopenic adults in the areas of prevention and treatment but no medications are currently proven. Future study in Asia should be straight forward to include intervention for prevention and treatment of sarcopenia.